May 2026
M	T	W	T	F	S	S
	1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Updated ASH / ISTH Clinical Guidelines 2024

Hemostasis

Jun 15, 2025, 06:11

Updated ASH / ISTH Clinical Guidelines 2024

American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients.

Clinical Takeaways:
Final authority remains 2023 ASH guidelines until full 2024 publication—but updates add precision, especially in non-surgical VTE and cancer-associated scenarios.

The 2024 iteration refines duration decision-making using newer DOACs and better incorporates bleeding risk and patient preferences.

Stay tuned for full 2024 guidelines expected in Blood Advances or via ASH/ISTH websites.

Title: American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients

Authors: Paul Monagle, Muayad Azzam, Rachel Bercovitz, Marisol Betensky , Rukhmi Bhat, Tina Biss, Brian Branchford, Leonardo R. Brandão, Anthony K. C. Chan, E. Vincent S. Faustino, Julie Jaffray, Sophie Jones, Hassan Kawtharany, Bryce A. Kerlin, Nicole Kucine, Riten Kumar , Christoph Male , Marie-Claude Pelland-Marcotte, Leslie Raffini, Chittalsinh Raulji, Reem A. Mustafa.

See detailed information in Hemostasis Today.

American Society of Hematology American Thrombosis and Hemostasis Network Anthony K C Chan ASH Fundamentals for Hematology Fellows program Brian Branchford Bryce A. Kerlin Chittalsinh Raulji Christoph Male E. Vincent S. Faustino Hassan Kawtharany Hematology Hemoastasis Today Julie Jaffray Leonardo R. Brandão Leslie Raffini Marie-Claude Pelland-Marcotte Marisol Betensky Muayad Azzam Nicole Kucine Paul Monagle Rachel Bercovitz Reem A. Mustafa Riten Kumar Rukhmi Bhat Sophie Jones Tina Biss updated guidelines venous thromboembolism

'

Julie Makani: WHO 2026 Guidelines on the Management of Childhood Illness for SCD

'

World Thalassaemia Day: Building Care Around Patients - Novo Nordisk Haemophilia and Haemoglobinopathies Foundation

'

Educational Grant Opportunities for Post–Secondary Students with Inherited Bleeding Disorders - Irish Haemophilia Society

'

Ragavendra Baliga: This Week's 3 Major Trials to Reshape Adjunctive Reperfusion Strategies in Acute Ischemic Stroke

'

Polycythemia Vera and Thrombosis: Pathogenesis and Prevention

NewsFeed

May 11, 2026, 16:52
Luke McLaughlin: Raising Awareness on Haemophilia Issues at ENIL Lead On
May 11, 2026, 16:49
Jeff Sternlicht: Normal LDL Does Not Always Mean Low Risk
May 11, 2026, 16:42
Archil Jaliashvili: From Managing Blood to Managing Oxygen Metabolism
May 11, 2026, 16:42
Heghine Khachatryan: Celebrating One Hundred Years of von Willebrand Disease with EHC
May 11, 2026, 16:34
Jane Hankins: Excited to Have Been a Part of the Faculty of ASH CRTI LA
May 11, 2026, 16:28
Conan McIlwrath at the Rare Bleeding Disorders Conference Representing The Haemophilia Society as Chair
May 11, 2026, 16:24
Anna A. Avagyan: Presenting Armenia’s Experience at SIOP Europe 2026
May 11, 2026, 16:18
Mohamed Elkhider: Raising Awareness on Aortic Dissection
May 11, 2026, 16:11
David McIntosh: A Pensioner’s Reflections on Blood Donation

Organizations

Updated ASH / ISTH Clinical Guidelines 2024

Clinical Takeaways:
Final authority remains 2023 ASH guidelines until full 2024 publication—but updates add precision, especially in non-surgical VTE and cancer-associated scenarios.

The 2024 iteration refines duration decision-making using newer DOACs and better incorporates bleeding risk and patient preferences.

Stay tuned for full 2024 guidelines expected in Blood Advances or via ASH/ISTH websites.

Hemostasis Today

Organizations

Updated ASH / ISTH Clinical Guidelines 2024

Clinical Takeaways: Final authority remains 2023 ASH guidelines until full 2024 publication—but updates add precision, especially in non-surgical VTE and cancer-associated scenarios.

The 2024 iteration refines duration decision-making using newer DOACs and better incorporates bleeding risk and patient preferences.

Stay tuned for full 2024 guidelines expected in Blood Advances or via ASH/ISTH websites.

Clinical Takeaways:
Final authority remains 2023 ASH guidelines until full 2024 publication—but updates add precision, especially in non-surgical VTE and cancer-associated scenarios.